BioCentury
ARTICLE | Finance

Analyst picks & changes

September 11, 2000 7:00 AM UTC

Shire Pharmaceuticals Group plc (LSE:SHP; SHPGY), Andover, U.K. Business: Neurological, Cancer Merrill Lynch analyst Nigel Barnes raised his rating to "buy" from "accumulate" due to a 12 percent drop ...